RI ESG Briefing, October 1: PFZW/PGGM hail execution drugs decision by pharma firm Mylan The round-up of the latest ESG news RI journalists - 1 October 2015 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
